Although the role of IL-6 in senescence-induced anti-tumour effects was reported in non-HCC [162], the role of IL6 in senescence-mediated anti-tumour effects in different types of liver cancers is still under investigation and seems to be dependent on the tumour type (E.G., personal communication). This evidence concerns the gene IL6 and neoplasm.